Sana Biotechnology (SANA) Interest & Investment Income (2020 - 2026)
Sana Biotechnology recorded quarterly Interest & Investment Income of $951000.0 in Q1 2026, down 25.47% quarter-over-quarter from $1.3 million in Q4 2025, and down 4.13% year-over-year from $992000.0 in Q1 2025.
Sana Biotechnology's Interest & Investment Income history runs 7 years deep, the most recent figure standing at $951000.0 for Q1 2026.
- In Q1 2026, Interest & Investment Income fell 4.13% year-over-year to $951000.0; the TTM figure through Mar 2026 stood at $3.8 million (down 54.83% YoY), while the FY2025 annual figure was $3.8 million, down 63.25% from the prior year.
- Interest & Investment Income came in at $951000.0 for Q1 2026 at Sana Biotechnology, down from $1.3 million in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $3.2 million in Q2 2024 to a low of $339000.0 in Q1 2022.
- A 5-year average of $1.7 million and a median of $1.6 million in 2022 frame the typical range for Interest & Investment Income.
- Across the five-year window, Interest & Investment Income surged 642.41% in 2022 and sank 81.98% in 2025, its largest moves.
- Sana Biotechnology's Interest & Investment Income stood at $1.6 million in 2022, then surged by 69.0% to $2.7 million in 2023, then plunged by 39.25% to $1.7 million in 2024, then dropped by 22.95% to $1.3 million in 2025, then slipped by 25.47% to $951000.0 in 2026.
- According to Business Quant data, Interest & Investment Income over the past three periods registered $951000.0, $1.3 million, and $1.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 7.90 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 114.80 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 305,000.00 |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 26.60 Mn |
| 10 | Sana Biotechnology | 890.09 Mn | 890.09 Mn | - | 951,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 951,000.00 |
| Dec 31, 2025 | 1.28 Mn |
| Sep 30, 2025 | 1.00 Mn |
| Jun 30, 2025 | 577,000.00 |
| Mar 31, 2025 | 992,000.00 |
| Dec 31, 2024 | 1.66 Mn |
| Sep 30, 2024 | 2.58 Mn |
| Jun 30, 2024 | 3.20 Mn |
| Mar 31, 2024 | 3.03 Mn |
| Dec 31, 2023 | 2.73 Mn |
| Sep 30, 2023 | 2.86 Mn |
| Jun 30, 2023 | 2.37 Mn |
| Mar 31, 2023 | 1.98 Mn |
| Dec 31, 2022 | 1.61 Mn |
| Sep 30, 2022 | 1.17 Mn |
| Jun 30, 2022 | 637,000.00 |
| Mar 31, 2022 | 339,000.00 |
| Dec 31, 2021 | 267,000.00 |
| Sep 30, 2021 | 158,000.00 |
| Jun 30, 2021 | 130,000.00 |
| Mar 31, 2021 | 121,000.00 |
| Dec 31, 2020 | 125,000.00 |
| Sep 30, 2020 | 148,000.00 |
| Jun 30, 2020 | 79,000.00 |
| Mar 31, 2020 | 395,000.00 |